| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Intellia Therapeutics, Inc. | 8,347,449 | 9.3% | EDGAR |
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | Intellia Therapeutics, Inc. | 11,412,449 | 12.7% | EDGAR |
| SC 13G/A | 2024-01-24 | STATE STREET CORP | Intellia Therapeutics, Inc. | - | 5.3% | EDGAR |
| SC 13G/A | 2024-01-08 | BlackRock Inc. | Intellia Therapeutics, Inc. | 9,010,695 | 10.1% | EDGAR |
| SC 13G/A | 2023-02-10 | ARK Investment Management LLC | Intellia Therapeutics, Inc. | 9,420,782 | 11.2% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | Intellia Therapeutics, Inc. | 2,421,952 | 2.9% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Intellia Therapeutics, Inc. | 7,810,226 | 9.3% | EDGAR |
| SC 13G | 2023-01-25 | BlackRock Inc. | Intellia Therapeutics, Inc. | 7,254,921 | 8.7% | EDGAR |
| SC 13G/A | 2022-02-14 | Nikko Asset Management Americas, Inc. | Intellia Therapeutics, Inc. | 2,753,903 | 3.7% | EDGAR |
| SC 13G/A | 2022-02-11 | REGENERON PHARMACEUTICALS, INC. | Intellia Therapeutics, Inc. | 3,702,995 | 5.0% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | Intellia Therapeutics, Inc. | 6,442,355 | 8.7% | EDGAR |
| SC 13G/A | 2022-02-09 | ARK Investment Management LLC | Intellia Therapeutics, Inc. | 7,916,882 | 10.6% | EDGAR |
| SC 13G | 2022-02-09 | FMR LLC | Intellia Therapeutics, Inc. | 3,877,772 | 5.2% | EDGAR |
| SC 13G/A | 2022-02-04 | Sumitomo Mitsui Trust Holdings, Inc. | Intellia Therapeutics, Inc. | 2,753,903 | 3.7% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | Intellia Therapeutics, Inc. | 5,620,376 | 7.6% | EDGAR |
| SC 13G/A | 2021-11-26 | ARK Investment Management LLC | Intellia Therapeutics, Inc. | 7,642,452 | 10.4% | EDGAR |
| SC 13G/A | 2021-02-16 | ARK Investment Management LLC | Intellia Therapeutics, Inc. | 11,191,670 | 17.4% | EDGAR |
| SC 13G/A | 2021-02-11 | Nikko Asset Management Americas, Inc. | Intellia Therapeutics, Inc. | 5,104,362 | 7.9% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | Intellia Therapeutics, Inc. | 5,131,197 | 8.0% | EDGAR |
| SC 13G/A | 2021-02-05 | Sumitomo Mitsui Trust Holdings, Inc. | Intellia Therapeutics, Inc. | 5,104,362 | 7.9% | EDGAR |